D-0444-2024 Class I Terminated
FDA drug recall D-0444-2024 was initiated by AvKARE on Mar 28, 2024 and is designated Class I. Reason for recall: Microbial contamination of a non-sterile product: potential Bacillus cereus contamination. The recall status is terminated (terminated Aug 23, 2024). Affected quantity: 153 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 24, 2024
- Initiation Date
- Mar 28, 2024
- Termination Date
- Aug 23, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 153 cartons
Product description
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.
Reason for recall
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
Distribution pattern
US Nationwide.
Code information
Lot: AW0221A Exp. 08/30/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0444-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026